Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers

Br J Cancer. 1998;77(3):466-71. doi: 10.1038/bjc.1998.74.


Using a bacterial fusion protein, a deleted colorectal carcinoma (DCC)-specific monoclonal antibody (MAb) 127-22 was established. Although MAb 127-22 reacted with almost all normal tissues, it did not react or only weakly reacted with many cancer cell lines, including colonic cancer lines, in flow cytometry. In Western immunoblots, the MAb reacted with a single 190-kDa molecule in a myeloma line Ara-10 extract. This component was scarcely detected in colonic cancer cell lines. Immunoblots of samples from 25 pairs of colonic cancers and adjacent normal tissues and from five adenoma tissues revealed that all normal colonic and adenoma tissues significantly expressed the DCC protein, whereas colonic cancer tissues showed poor expression. These results indicate not only deletion of and lowered mRNA expression of the DCC gene, but also marked reduction of DCC protein occurred in colonic cancer tissues. In addition, colonic cancer patients with liver metastasis expressed significantly lower levels of DCC than those without, suggesting the prognostic value of DCC expression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Blotting, Western
  • Cell Adhesion Molecules / analysis*
  • Cell Adhesion Molecules / genetics
  • Cell Adhesion Molecules / immunology
  • Colonic Neoplasms / metabolism*
  • DCC Receptor
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / secondary
  • Mice
  • RNA, Messenger / analysis
  • Receptors, Cell Surface
  • Tumor Suppressor Proteins*


  • Antibodies, Monoclonal
  • Cell Adhesion Molecules
  • DCC Receptor
  • DCC protein, human
  • Dcc protein, mouse
  • RNA, Messenger
  • Receptors, Cell Surface
  • Tumor Suppressor Proteins